Improved treatment adherence through behavioural interventions among patients with chronic myeloid leukaemia

被引：0
|
作者：
Shajan, Sheena [1 ]
Surendran, V. [1 ]
Ganesan, Prasanth [1 ]
机构：
[1] Inst Canc Res, Chennai, Tamil Nadu, India
来源：
PSYCHO-ONCOLOGY | 2016年 / 25卷 / SP. S3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [21] Impact of imatinib treatment on renal function in chronic myeloid leukaemia patients
    Singh, Avinash Kumar
    Hussain, Salman
    Ahmed, Rayaz
    Agrawal, Narendra
    Bhurani, Dinesh
    Klugar, Miloslav
    Sharma, Manju
    NEPHROLOGY, 2022, 27 (04) : 318 - 326
  • [22] A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia
    Marina Dokic
    Ivana Urosevic
    Ivanka Savic
    Borivoj Sekulic
    Aleksandar Savic
    Ivana Milosevic
    Nebojsa Rajic
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 156 - 158
  • [23] A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia
    Dokic, Marina
    Urosevic, Ivana
    Savic, Ivanka
    Sekulic, Borivoj
    Savic, Aleksandar
    Milosevic, Ivana
    Rajic, Nebojsa
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 : S156 - S158
  • [24] Treatment of chronic myeloid leukaemia: Lessons and challenges
    Goldman, JM
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 189 - 192
  • [25] Treatment of chronic myeloid leukaemia lessons and challenges
    John M. Goldman
    International Journal of Hematology, 2002, 76 : 189 - 192
  • [26] MYLERAN IN CHRONIC MYELOID LEUKAEMIA - RESULTS OF TREATMENT
    GALTON, DAG
    LANCET, 1953, 264 (JAN31): : 208 - 213
  • [27] Current approach to the treatment of chronic myeloid leukaemia
    Pasic, Ivan
    Lipton, Jeffrey H.
    LEUKEMIA RESEARCH, 2017, 55 : 65 - 78
  • [28] Imatinib mesylate in the treatment of chronic myeloid leukaemia
    Druker, BJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) : 963 - 971
  • [29] Adherence to imatinib therapy is the critical factor for achieving molecular responses in patients with chronic myeloid leukaemia
    Marin, D.
    Milojkovic, D.
    Bua, M.
    Apperley, J.
    Reid, A.
    Rezvani, K.
    Foroni, L.
    Goldman, J.
    Marin, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 81 - 81
  • [30] Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia - A population-based analysis
    Menzin, J
    Lang, K
    Earle, CC
    Glendenning, A
    DRUGS & AGING, 2004, 21 (11) : 737 - 746
12345